Login to Your Account

Financings Roundup

Unigene Hands Tarsa Phase III Asset as $24M Series A Closes

By Catherine Hollingsworth

Wednesday, October 21, 2009
No Abstract

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription